Say–Meyer syndrome
Say–Meyer syndrome is a rare genetic disorder characterized by a combination of neurological and developmental abnormalities. The syndrome is named after the researchers who first described it, Burton Say and Arthur Meyer.
Clinical Features[edit | edit source]
Individuals with Say–Meyer syndrome typically present with a range of symptoms that may include:
- Intellectual disability
- Seizures
- Microcephaly (abnormally small head size)
- Hypotonia (reduced muscle tone)
- Developmental delay
- Facial dysmorphisms such as a broad nasal bridge, wide-set eyes, and a small jaw
Genetics[edit | edit source]
Say–Meyer syndrome is believed to be inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in Say–Meyer syndrome have not yet been identified.
Diagnosis[edit | edit source]
Diagnosis of Say–Meyer syndrome is primarily based on clinical evaluation and the presence of characteristic symptoms. Genetic testing may be used to rule out other conditions with similar presentations. Neuroimaging techniques such as MRI or CT scan may be employed to identify structural abnormalities in the brain.
Management[edit | edit source]
There is currently no cure for Say–Meyer syndrome. Management of the condition is symptomatic and supportive, focusing on improving the quality of life for affected individuals. This may include:
- Anticonvulsant medications to control seizures
- Physical therapy to address hypotonia and improve motor skills
- Speech therapy to assist with communication difficulties
- Special education programs to support learning and development
Prognosis[edit | edit source]
The prognosis for individuals with Say–Meyer syndrome varies depending on the severity of symptoms. Early intervention and supportive care can help improve outcomes and enhance the quality of life.
See Also[edit | edit source]
Related Pages[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD